Current policy for allocation of donor livers in the Netherlands advantages primary sclerosing cholangitis patients on the liver transplantation waiting list-a retrospective study-Reference-Cited by-同舟云学术

Current policy for allocation of donor livers in the Netherlands advantages primary sclerosing cholangitis patients on the liver transplantation waiting list-a retrospective study

Published:2017-12-05 Issue:6 Volume:31 Page:590-599
ISSN:0934-0874
Container-title:Transplant International
language:en
Short-container-title:Transpl Int

Author:

Goet Jorn C.¹^ORCID,Hansen Bettina E.¹²³^ORCID,Tieleman Madelon¹,van Hoek Bart⁴^ORCID,van den Berg Aad P.⁵,Polak Wojciech G.⁶^ORCID,Dubbeld Jeroen⁷^ORCID,Porte Robert J.⁸,Konijn-Janssen Cynthia⁹,de Man Robert A.¹^ORCID,Metselaar Herold J.¹^ORCID,de Vries Annemarie C.¹

Affiliation:

1. Department of Gastroenterology and Hepatology; Erasmus University Medical Center; Rotterdam The Netherlands

2. Toronto Center for Liver Disease; Toronto General Hospital; University of Toronto; Toronto Canada

3. Institute of Health Policy, Management and Evaluation; University of Toronto; Toronto Canada

4. Department of Gastroenterology and Hepatology; Leiden University Medical Center; Leiden The Netherlands

5. Department of Gastroenterology and Hepatology; University Medical Center Groningen; Groningen The Netherlands

6. Department of Surgery; Erasmus University Medical Center; Rotterdam The Netherlands

7. Department of Surgery; Leiden University Medical Center; Leiden The Netherlands

8. Department of Surgery; University Medical Center Groningen; Groningen The Netherlands

9. Dutch Transplantation Foundation; Leiden The Netherlands

Funder

Foundation for Liver and Gastrointestinal Research

Publisher

Frontiers Media SA

Subject

Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/tri.13097/fullpdf

Reference38 articles.

1. Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology;Chapman;Gut,1980

2. Primary sclerosing cholangitis;Hirschfield;Lancet,2013

3. EASL clinical practice guidelines: management of cholestatic liver diseases;European Association for the Study of the L;J Hepatol,2009

4. Survival after liver transplantation in the United States: a disease-specific analysis of the UNOS database;Roberts;Liver Transpl,2004

5. Evolving frequency and outcomes of liver transplantation based on etiology of liver disease;Singal;Transplantation,2013

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of a donor for liver transplantation;The Liver Graft Before Transplantation;2024

2. Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)—A European Society of Organ Transplantation (ESOT) Consensus Statement;Transplant International;2023-09-29

3. ECCO Guidelines on Extraintestinal Manifestations in Inflammatory Bowel Disease;Journal of Crohn's and Colitis;2023-06-23

4. Inflammatory conditions play a role in recurrence of PSC after liver transplantation: An international multicentre study;JHEP Reports;2022-12

5. We Are Not Immune: Racial and Ethnic Disparities in Autoimmune Liver Diseases;Hepatology;2021-08-10